Crawford Investment Counsel’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.39M | Buy |
15,387
+1,260
| +9% | +$116K | 0.02% | 198 |
|
|
2025
Q4 | $1.27M | Buy |
14,127
+1,394
| +11% | +$132K | 0.02% | 208 |
|
|
2025
Q3 | $1.25M | Buy |
12,733
+856
| +7% | +$84.8K | 0.02% | 206 |
|
|
2025
Q2 | $1.08M | Sell |
11,877
-585
| -5% | -$56.6K | 0.02% | 206 |
|
|
2025
Q1 | $1.41M | Buy |
12,462
+1,370
| +12% | +$147K | 0.03% | 200 |
|
|
2024
Q4 | $1.17M | Buy |
11,092
+1,752
| +19% | +$188K | 0.02% | 201 |
|
|
2024
Q3 | $1.01M | Buy |
9,340
+485
| +5% | +$52.9K | 0.02% | 207 |
|
|
2024
Q2 | $961K | Buy |
8,855
+333
| +4% | +$39.3K | 0.02% | 199 |
|
|
2024
Q1 | $1.12M | Sell |
8,522
-113
| -1% | -$14.1K | 0.02% | 185 |
|
|
2023
Q4 | $1.05M | Buy |
8,635
+693
| +9% | +$77.3K | 0.02% | 186 |
|
|
2023
Q3 | $891K | Sell |
7,942
-130
| -2% | -$16.5K | 0.02% | 191 |
|
|
2023
Q2 | $1.18M | Buy |
8,072
+240
| +3% | +$32.6K | 0.02% | 184 |
|
|
2023
Q1 | $1.01M | Buy |
7,832
+1,262
| +19% | +$158K | 0.02% | 184 |
|
|
2022
Q4 | $838K | Sell |
6,570
-64
| -1% | -$7.43K | 0.02% | 199 |
|
|
2022
Q3 | $694K | Sell |
6,634
-454
| -6% | -$49.8K | 0.02% | 203 |
|
|
2022
Q2 | $745K | Sell |
7,088
-307
| -4% | -$36.4K | 0.02% | 206 |
|
|
2022
Q1 | $946K | Sell |
7,395
-823
| -10% | -$99.2K | 0.02% | 201 |
|
|
2021
Q4 | $1.01M | Sell |
8,218
-3,394
| -29% | -$444K | 0.02% | 199 |
|
|
2021
Q3 | $1.65M | Sell |
11,612
-2,107
| -15% | -$310K | 0.03% | 176 |
|
|
2021
Q2 | $2.14M | Buy |
13,719
+940
| +7% | +$152K | 0.04% | 171 |
|
|
2021
Q1 | $1.99M | Sell |
12,779
-79,679
| -86% | -$12.3M | 0.04% | 164 |
|
|
2020
Q4 | $13.8M | Sell |
92,458
-7,015
| -7% | -$991K | 0.34% | 65 |
|
|
2020
Q3 | $13.1M | Buy |
99,473
+161
| +0.2% | +$21K | 0.36% | 61 |
|
|
2020
Q2 | $11.5M | Buy |
99,312
+2,226
| +2% | +$257K | 0.33% | 63 |
|
|
2020
Q1 | $9.53M | Sell |
97,086
-2,996
| -3% | -$393K | 0.32% | 67 |
|
|
2019
Q4 | $14.5M | Buy |
100,082
+1,066
| +1% | +$147K | 0.38% | 61 |
|
|
2019
Q3 | $13.2M | Sell |
99,016
-4,182
| -4% | -$540K | 0.37% | 62 |
|
|
2019
Q2 | $11.8M | Buy |
103,198
+4,419
| +4% | +$518K | 0.33% | 67 |
|
|
2019
Q1 | $12.2M | Buy |
98,779
+4,805
| +5% | +$546K | 0.36% | 61 |
|
|
2018
Q4 | $9.46M | Buy |
93,974
+60,637
| +182% | +$6.82M | 0.32% | 69 |
|
|
2018
Q3 | $4.25M | Buy |
33,337
+28,649
| +611% | +$3.41M | 0.13% | 93 |
|
|
2018
Q2 | $507K | Buy |
4,688
+979
| +26% | +$107K | 0.02% | 201 |
|
|
2018
Q1 | $393K | Buy |
3,709
+1,962
| +112% | +$228K | 0.01% | 210 |
|
|
2017
Q4 | $205K | Buy |
+1,747
| New | +$198K | 0.01% | 246 |
|
Other funds holding ZBH
VCM
VPM
Crawford Investment Counsel's ZBH Position: Q1 2026 in Review
Crawford Investment Counsel increased its Zimmer Biomet (ZBH) stake by 8.9% in Q1 2026, buying an estimated $116K and bringing the position to 15,387 shares worth $1.39M. The position accounts for 0.02% of the portfolio, ranked #198.
Crawford Investment Counsel first reported a position in ZBH in Q4 2017 and has held it in 34 quarters since. The position peaked at $14.5M in Q4 2019. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Crawford Investment Counsel held 15,387 shares of Zimmer Biomet worth $1.39M as of Q1 2026.
- Crawford Investment Counsel bought 1,260 Zimmer Biomet shares in Q1 2026, an estimated $116K.
- Zimmer Biomet made up 0.02% of Crawford Investment Counsel's portfolio in Q1 2026, its #198 holding.
- Crawford Investment Counsel first reported a position in Zimmer Biomet in Q4 2017 and has held it in 34 quarters since.
- Crawford Investment Counsel's Zimmer Biomet position peaked at $14.5M in Q4 2019.
- 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.